文献速递腹部MR

肝脏MRI质子密度脂肪分数预测肥胖患者糖尿病风险:剂量-反应研究

Liver MRI-derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study.
PubMed 文献 · Radiology · 2025-01-01

该回顾性研究纳入683例接受MRI测定质子密度脂肪分数(PDFF)并口服75g葡萄糖耐量试验的肥胖成人,按PDFF分级分析其与糖尿病前期或2型糖尿病风险的剂量-反应关系,并探讨肝酶的介导作用。结果显示PDFF每增加1%与糖尿病前期和2型糖尿病风险升高相关(OR 1.04),重度脂肪变(PDFF≥25%)与两者风险均升高相关(OR分别为3.49和3.45),且该关联部分由天冬氨酸氨基转移酶(27.3%)和丙氨酸氨基转移酶(38.8%)介导。

要点

  • 肝脏PDFF每升高1%,糖尿病前期和2型糖尿病风险均升高(OR 1.04,95%CI 1.02–1.07,P<.001)。
  • PDFF≥25%的重度脂肪变与糖尿病前期(OR 3.49)和2型糖尿病(OR 3.45)风险升高相关。
  • 血糖异常患者平均肝脏PDFF高于血糖正常者(19.7% vs 12.9%,P<.001)。

核心结论

  • 在肥胖患者中,肝脏MRI衍生的PDFF与糖尿病前期和2型糖尿病的风险强烈相关,呈剂量-反应关系,且部分由肝酶介导。

研究设计与样本

  • 回顾性研究,纳入2020年9月至2023年12月接受MRI测定PDFF并口服75g葡萄糖耐量试验的肥胖成人683例(平均年龄33岁±6.5[SD],男性121例),并在独立队列中验证。

诊断标准与关键数值

  • 按PDFF将脂肪变程度分为<5%、5%至<15%、15%至<25%、≥25%四级,并以口服葡萄糖耐量试验结果分为血糖正常、糖尿病前期和2型糖尿病。

临床应用与阅片要点

  • 肝脏PDFF每增加1%,糖尿病前期和2型糖尿病风险升高(OR 1.04,95%CI 1.02–1.07,P<.001)。
  • PDFF≥25%的重度脂肪变与糖尿病前期风险升高相关(OR 3.49,95%CI 1.35–9.02,P=.01),也与2型糖尿病风险升高相关(OR 3.45,95%CI 1.30–9.13,P=.01)。
  • 血糖异常患者平均肝脏PDFF高于血糖正常者(19.7% vs 12.9%,P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Metabolic dysfunction-associated steatotic liver disease is linked to type 2 diabetes mellitus, but its relationship with a risk of prediabetes or type 2 diabetes in patients with obesity remains unclear. MRI-derived proton density fat fraction (PDFF) can accurately quantify liver fat. Purpose To define the precise dose-response relationship between liver MRI-derived PDFF and risk of prediabetes or type 2 diabetes in patients with obesity, and to explore the mediating role of liver enzymes. Materials and Methods This retrospective study included adult patients with obesity who underwent MRI to determine PDFF and who were administered a 75-g oral glucose tolerance test between September 2020 and December 2023. Based on oral glucose tolerance test results, patients were classified as having normal glucose tolerance, prediabetes, or type 2 diabetes. Steatosis severity was categorized by PDFF (<5%, 5% to <15%, 15% to <25%, or ≥25%). Multinomial logistic regression assessed the association between liver PDFF and prediabetes or type 2 diabetes. Mediation analysis evaluated the levels of alanine aminotransferase and aspartate aminotransferase. The findings were validated in an independent cohort. Results A dose-response relationship was found between liver PDFF and abnormal glucose metabolism in 683 patients (mean age, 33 years ± 6.5 [SD]; 121 male patients). Each 1% increase in PDFF was associated with higher odds of both prediabetes and type 2 diabetes (odds ratio [OR], 1.04; 95% CI: 1.02, 1.07; P < .001). Severe steatosis (PDFF ≥ 25%) was associated with higher odds of prediabetes (OR, 3.49; 95% CI: 1.35, 9.02; P = .01) and type 2 diabetes (OR, 3.45; 95% CI: 1.30, 9.13; P = .01). The association was partially mediated by aspartate aminotransferase (mediation proportion, 27.3%) and alanine aminotransferase (mediation proportion, 38.8%) (P < .001 for both). These findings were validated because patients with dysglycemia had higher mean liver PDFF than did patients with normoglycemia (19.7% vs 12.9%, respectively; P < .001). Conclusion In patients with obesity, the liver MRI-derived PDFF was strongly associated with the odds of prediabetes and type 2 diabetes, showing a dose-response relationship partially mediated by liver enzymes. © The Authors 2025. Published by the Radiological Society of North America under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Reeder and Starekova in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Deng M, Li Z, Sun L, et al. Liver MRI-derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study. Radiology. 2025. PMID: 41117648. doi:10.1148/radiol.250026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。